EUFOREA treatment algorithm for allergic rhinitis.

摘要: Allergic rhinitis (AR) is the most common chronic inflammatory disease, affecting an estimated 100 million Europeans (1). Despite a substantial burden on individuals, society and health economies (2), AR remains under-diagnosed, under-estimated (in terms of severity), under-treated (3). Although effective safe treatments exist, patients wait too long to seek medical advice, often preferring self-manage at drug stores pharmacy (4).